【结 构 式】 |
【分子编号】16159 【品名】tert-butyl 4-(3-nitro-2-pyridinyl)tetrahydro-1(2H)-pyrazinecarboxylate 【CA登记号】 |
【 分 子 式 】C14H20N4O4 【 分 子 量 】308.33736 【元素组成】C 54.54% H 6.54% N 18.17% O 20.76% |
合成路线1
该中间体在本合成路线中的序号:(III)Nucleophilic aromatic substitution of 2-chloro-3-nitropyridine (II) with excess piperazine (I) in acetonitrile at room temperature produces 1-(3-nitro-2-pyridyl)piperazine. Protection of the free piperazine nitrogen by treatment with di-tert-butyldicarbonate affords nitropyridine (III). Reduction of the nitro group to the amine is accomplished via hydrogenation (40 psi) over palladium on carbon. Treatment of the aminopyridine with acetaldehyde and sodium cyanoborohydride in methanol affords the (ethylamino)pyridine (IV). Removal of the BOC protecting group with trifluoroacetic acid and coupling of the resulting 1-[3-(ethylamino)pyridyl]piperazine with 5-methoxyindole-2-carboxylic acid using 1-ethyl-3-(dimethylaminopropyl)carbodiimide (EDC) or 1,1'-carbonyldiimidazole (CDI) affords U-87201 (V). Dissolution of (V) in methanol, treatment with 1 eq of methanesulfonic acid, and the addition of diethyl ether results in the precipitation of atevirdine mesylate.
【1】 Richman, D.D.; Fischl, M.A.; Grieco, M.H.; et al.; The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. New Engl J Med 1987, 317, 4, 192-7. |
【2】 Tan, C.-K.; Busso, M.; Romero, D.L.; et al.; Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1991, 88, 19, 8806-10. |
【3】 Romero, D.L.; Atevirdine Mesylate. Drugs Fut 1994, 19, 1, 9. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(II) | 10321 | 2-Chloro-3-nitropyridine | 5470-18-8 | C5H3ClN2O2 | 详情 | 详情 |
(III) | 16159 | tert-butyl 4-(3-nitro-2-pyridinyl)tetrahydro-1(2H)-pyrazinecarboxylate | C14H20N4O4 | 详情 | 详情 | |
(IV) | 14880 | tert-butyl 4-[3-(ethylamino)-2-pyridinyl]tetrahydro-1(2H)-pyrazinecarboxylate | C16H26N4O2 | 详情 | 详情 | |
(V) | 63849 | {4-[3-(ethylamino)-2-pyridinyl]-1-piperazinyl}(1H-indol-2-yl)methanone | C20H23N5O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(III)The synthesis of delavirdine mesylate is depicted in Scheme 19654001a: The first three chemical steps are the same as those used for the synthesis of atevirdine mesylate (ATV, U-87201E) (2, 3). Nucleophilic aromatic substitution of 2-chloro-3-nitropyridine (II) with excess piperazine in acetonitrile at room temperature produces 1-(3-nitro-2-pyridyl)piperazine. Protection of the free piperazine nitrogen by treatment with di-tert-butyldicarbonate affords nitropyridine (III). Reduction of the nitro group to the amine is accomplished via hydrogenation (40 psi) over palladium on carbon. Treatment of the aminopyridine with acetone and sodium cyanoborohydride in methanol affords the 3-(1-methylethylamino)pyridine (IV). Removal of the BOC protecting group with trifluoroacetic acid and coupling of the resulting 1-[3-(1-methylethylamino)pyridyl]piperazine with 5-nitroindole-2-carboxylic acid using 1-ethyl-3-(dimethylaminopropyl)carbodiimide (EDC) or 1,1'-carbonyldiimidazole (CDI) affords (V). Catalytic reduction of the nitro group and treatment of the resulting amine with methanesulfonyl chloride provides U-90152. Dissolution of U-90152 in acetonitrile and treatment with 1 eq of methanesulfonic acid results in the precipitation of delavirdine mesylate.
【1】 Romero, D.L.; Atevirdine mesylate (U-87201E). Drugs Fut 1994, 19, 1, 7-12. |
【2】 Aristoff, P.A.; Romero, D.L.; Palmer, J.R.; Thomas, R.C.; Smith, H.W. (Pharmacia Corp.); Diaromatic substd. cpds. as anti-HIV-1 agents. US 5563142 . |
【3】 Busso, M.; Romero, D.L.; Biles, C.; Genin, M.J.; Tarpley, W.G.; Morge, R.A.; Reusser, F.; Althaus, I.W.; Thomas, R.C.; Resnick, L.; Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: Structure-activity relationships of novel substituted indole analogues and the identification oF (U-90152S), a second-generation clinical candidate. J Med Chem 1993, 36, 10, 1505-8. |
【4】 Romero, D.L.; Delavirdine Mesylate. Drugs Fut 1994, 19, 3, 238. |
【5】 Tan, C.-K.; Busso, M.; Romero, D.L.; et al.; Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci USA 1991, 88, 19, 8806-10. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(II) | 10321 | 2-Chloro-3-nitropyridine | 5470-18-8 | C5H3ClN2O2 | 详情 | 详情 |
(III) | 16159 | tert-butyl 4-(3-nitro-2-pyridinyl)tetrahydro-1(2H)-pyrazinecarboxylate | C14H20N4O4 | 详情 | 详情 | |
(IV) | 16160 | tert-butyl 4-[3-(isopropylamino)-2-pyridinyl]tetrahydro-1(2H)-pyrazinecarboxylate | C17H28N4O2 | 详情 | 详情 | |
(V) | 16161 | [4-[3-(isopropylamino)-2-pyridinyl]piperazino](5-nitro-1H-indol-2-yl)methanone | C21H24N6O3 | 详情 | 详情 |